David Burmedi

423 total citations
8 papers, 330 citations indexed

About

David Burmedi is a scholar working on Physical Therapy, Sports Therapy and Rehabilitation, Neuropsychology and Physiological Psychology and Epidemiology. According to data from OpenAlex, David Burmedi has authored 8 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Physical Therapy, Sports Therapy and Rehabilitation, 4 papers in Neuropsychology and Physiological Psychology and 4 papers in Epidemiology. Recurrent topics in David Burmedi's work include Older Adults Driving Studies (5 papers), Ophthalmology and Visual Impairment Studies (4 papers) and Aging and Gerontology Research (4 papers). David Burmedi is often cited by papers focused on Older Adults Driving Studies (5 papers), Ophthalmology and Visual Impairment Studies (4 papers) and Aging and Gerontology Research (4 papers). David Burmedi collaborates with scholars based in Germany, Australia and Belgium. David Burmedi's co-authors include Stefanie Becker, Hans‐Werner Wahl, Ines Himmelsbach, Vera Heyl, Oliver Schilling, Jean-Pierre M. Ayoub, Hyo S. Han, George Somlo, Jane Qian and Vincent L. Giranda and has published in prestigious journals such as Journal of Clinical Oncology, Psychology and Aging and The Gerontologist.

In The Last Decade

David Burmedi

8 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Burmedi Germany	7	145	65	61	50	42	8	330
Barbara Silverstone United States	7	67 0.5×	33 0.5×	32 0.5×	53 1.1×	23 0.5×	17	309
Jennifer K. Bambara United States	9	52 0.4×	29 0.4×	25 0.4×		9 0.2×	10	297
Archana Singh India	3	15 0.1×		169 2.8×	49 1.0×	89 2.1×	5	343
Beverly P. Horowitz United States	10	10 0.1×	1 0.0×	43 0.7×	73 1.5×	23 0.5×	23	332
Susan T. Jackson United States	9	20 0.1×		17 0.3×	7 0.1×	16 0.4×	19	347
Anneli Nyman Sweden	12	40 0.3×		52 0.9×	19 0.4×	22 0.5×	28	318
Sofia Santos Portugal	12	29 0.2×	4 0.1×	17 0.3×	2 0.0×	12 0.3×	57	370
John W. Lace United States	13	103 0.7×		66 1.1×	4 0.1×	83 2.0×	39	366
Ving Fai Chan United Kingdom	14	303 2.1×	248 3.8×	2 0.0×		39 0.9×	51	440

Countries citing papers authored by David Burmedi

Since Specialization

Citations

This map shows the geographic impact of David Burmedi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Burmedi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Burmedi more than expected).

Fields of papers citing papers by David Burmedi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Burmedi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Burmedi. The network helps show where David Burmedi may publish in the future.

Co-authorship network of co-authors of David Burmedi

This figure shows the co-authorship network connecting the top 25 collaborators of David Burmedi. A scholar is included among the top collaborators of David Burmedi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Burmedi. David Burmedi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Han, Hyo S., Véronique Dièras, Michael Friedländer, et al.. (2015). Phase III randomized, placebo-controlled trial of carboplatin (C) and paclitaxel (P) with/without veliparib (ABT-888) in HER2- BRCA-associated locally advanced or metastatic breast cancer (BC).. Journal of Clinical Oncology. 33(28_suppl). 155–155. 9 indexed citations

Puhalla, Shannon, Hyo S. Han, Véronique Dièras, et al.. (2015). Phase 3 randomized, placebo-controlled trial of carboplatin (C) and paclitaxel (P) with/without veliparib (ABT-888) in HER2-BRCA-associated locally advanced or metastatic breast cancer (BC).. Journal of Clinical Oncology. 33(15_suppl). TPS1102–TPS1102. 2 indexed citations

Becker, Stefanie, Hans‐Werner Wahl, Oliver Schilling, & David Burmedi. (2005). Assistive Device Use in Visually Impaired Older Adults: Role of Control Beliefs. The Gerontologist. 45(6). 739–746. 19 indexed citations

Wahl, Hans‐Werner, Stefanie Becker, Oliver Schilling, David Burmedi, & Ines Himmelsbach. (2005). Primäre und Sekundäre Kontrolle versus Hartnäckige Zielverfolgung und Flexible Zielanpassung:. Zeitschrift für Entwicklungspsychologie und Pädagogische Psychologie. 37(2). 57–68. 9 indexed citations

Wahl, Hans‐Werner, Stefanie Becker, David Burmedi, & Oliver Schilling. (2004). The Role of Primary and Secondary Control in Adaptation to Age-Related Vision Loss: A Study of Older Adults With Macular Degeneration.. Psychology and Aging. 19(1). 235–239. 67 indexed citations

Wahl, Hans‐Werner, Oliver Schilling, Stefanie Becker, & David Burmedi. (2003). A German Research Program on the Psychosocial Adaptation to Age-Related Vision Impairment. European Psychologist. 8(3). 168–177. 13 indexed citations

Burmedi, David, Stefanie Becker, Vera Heyl, Hans‐Werner Wahl, & Ines Himmelsbach. (2002). Behavioral consequences of age-related low vision. 4(1). 15–45. 76 indexed citations

Burmedi, David, Stefanie Becker, Vera Heyl, Hans‐Werner Wahl, & Ines Himmelsbach. (2002). Emotional and social consequences of age-related low vision. 4(1). 47–71. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact